In our series, glucocorticoid treatment at early CT image stages was beneficial in high-risk patients with moderate-to-severe COVID-19, although it did not reach statistical significance, possibly because of the small sample size.
← all excerpts
Effect of methylprednisolone in reducing severe COVID-19 and mortality in high-risk patients: A retrospective study.
1
—
—